Monthly Archives: December 2014

Page 5 of 512345

Important, because Deaths Fall second year in a row , despite growing and aging populationThe American Cancer Society reports that the number of deaths from cancer in the United States dropped slightly, the second consecutive year.Over 3,000 less people died of cancer between 2003 and 2004, over the previous year. This is small compared to the total annual death rate of more than 500 But it could mean the beginning of a very welcome return.

Breast cancer rates hovered around 30 cases per 100,000 women to about 1990, when they started to decrease in 2003 of approximately 25 cases per 100,000. Continue reading

Avastin is also evaluated in earlier stage trials as a potential therapy in a variety of solid tumors and hematologic malignancies. In April 2006, Genentech sBLA for Avastin plus platinum-based chemotherapy for first-line treatment of advanced non – small cell lung cancer than non – squamous histology. Clinical trialsdy directed against VEGF could suppress angiogenesis and tumor growth in preclinical models, provides compelling evidence that VEGF plays a critical role in tumor growth. Clinical studies with a humanized version of the antibody, Avastin, began in 1997.. About the Avastin Development Programon data showing that can VEGF play a broad role in a range of cancers based is Genentech are pursuing a broad development program for Avastin that several currently 130 clinical studies over 25 types of cancer.

About ColorectalAccording to the American Cancer Society , more than 150 patients die every day from cancer in the United States. Colorectal cancer is the second leading cause of cancer death in the United States and the third most commonly diagnosed cancer. The ACS estimates that 148,610 new cases of colorectal cancer diagnosed and 55,170 cancer deaths in 2006. Continue reading

There is currently no effective vaccine and the existing treatment is expensive and often causes severe side effects. The success rate varies between 50-80 percent so many sufferers are not helped by current approaches.

He said vaccines for HIV have been tried, but with little success. ‘There is antiretroviral treatment but not eradicate HIV, just keeps them under control of the time. Also very expensive and also very expensive and therefore not available on a global scale, ‘Beard said the program would be to develop a pipeline and testing, provide vaccines and novel treatments in time. -ion can change the hand you favorto do every time we perform a simple task, like pushing an elevator button or reaching a cup of coffee, the brain races to decide whether the left or right hand the job. But the left hand is more likely to win if a certain region of the brain receives magnetic stimulation. According to new research from the University of California, Berkeley. Continue reading

Page 5 of 512345